Gunzburg: a cocktail of antibodies to COVID-19 will be tested on healthy volunteers

“The first phase is healthy volunteers.

In three weeks, we will begin the introduction of the drug, which has already been developed in the required quantities, ”RIA Novosti quotes Gunzburg.

According to him, after the first phase, experts will decide whether to conduct a second phase with sick volunteers.

Earlier, Gunzburg said that the effectiveness of the Sputnik V vaccine against severe cases of COVID-19 caused by the Omicron strain, according to the latest data, is about 89%.